Requires financial disclosure statements of state agency executive directors to be public records available for inspection and duplication.
Provides the Land Use Commission with the power to amend, revise, or modify a decision and order granting a district boundary amendment, or fine a petitioner, when there has been a finding by the Land Use Commission that a petitioner or its successors or assigns have not adhered to a representation made by the petitioner or a condition imposed by the commission, regardless of whether there has been substantial commencement of use of the land. Defines "substantial commencement". Effective 1/1/2020. (SD2)
Authorizes a pharmacy to provide a customized patient medication package to any patient of an institutional facility or any member of the general public, subject to certain conditions.
Prohibits a merchant in the State from adopting a warranty policy that requires a purchaser to pay an additional fee to obtain a repair, replacement, or refund for goods returned pursuant to the warranty. Defines "merchant in the State". (SD1)
Makes intentionally or knowingly causing bodily injury to certain health care facility workers a Class C felony.
Requires the executive office on aging to coordinate with the University of Hawaii center on aging to implement an active aging initiative. Establishes an active aging advisory committee. Appropriates funds.
Limits medical malpractice liability for residents and fellows in accredited residency and fellowship programs acting under the supervision of a licensed physician.
Appropriates funds for the Healthy Aging Partnership Program to further the program's role in improving the health and well-being of Hawaii's kupuna. Effective 7/1/2050. (SD1)
Requires reimbursement for prescriptions issued pursuant to the our care, our choice act, regardless of the prescription drug coverage provisions of the patient's health insurance. Establishes penalties for pharmacies and pharmacists, or their agents, that refuse to honor prescriptions issued under the our care, our choice act.
Exempts the sales of mobility enhancing equipment sold by prescription, prosthetic devices, prescription drugs sold pursuant to a prescription, diabetic supplies, medical oxygen, and human blood and its derivatives from the general excise tax for taxable years beginning after December 31, 2018. Amends the definitions of "prosthetic device" and "prescription drugs".
